See whether Helium helps you make better-informed decisions. Try every Pro Trader feature for 30 days. No credit card required.
Try every Pro Trader feature for 30 days. No credit card required.
Methodologically transparent; a retrospective single-center study in MASLD with severe obesity uses CT-based PMI trajectories and survival analyses to relate muscle loss to outcomes, while explicitly acknowledging limitations and avoiding sensationalism or ideological framing.
Retrospective single-center study of MASLD patients with BMI ≥35 undergoing orthotopic liver transplantation (2015–2023) assesses psoas muscle index trajectories via CT and their relation to survival over up to 5 years.
Limited to provided article; may miss broader context
2026 © Helium Trades
Privacy Policy & Disclosure
* Disclaimer: Nothing on this website constitutes investment advice, performance data or any recommendation that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person. Helium Trades is not responsible in any way for the accuracy
of any model predictions or price data. Any mention of a particular security and related prediction data is not a recommendation to buy or sell that security. Investments in securities involve the risk of loss. Past performance is no guarantee of future results. Helium Trades is not responsible for any of your investment decisions,
you should consult a financial expert before engaging in any transaction.
